Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2017
Michael Taylor, M.D., Ph.D., FRCS
Targeting Circulating Metastatic Cells as a Novel Approach for Cancer Therapy
Read More
2017
Ben Stanger, Ph.D., M.D.
Predicting tumor subtype by liquid biopsy
Read More
2017
Joseph Sparano, M.D.
Closing the Door on Metastasis: A New Biomarker and Treatment Paradigm
Read More
2017
Barbara Savoldo, Ph.D., M.D.
Exploiting the inducible Caspase9 safety switch to pharmacologically modulate CD19.CAR-T cell function...
Read More
2017
Jeffrey Ravetch, Ph.D., M.D.
Advancing Fc-optimized anti-CD40 antibody into phase I clinical trial
Read More
2017
Jong Park, Ph.D.
Genomic predictors of aggressive and lethal prostate cancer in African American men
Read More
2017
Duane Mitchell, M.D., Ph.D.
Selective expansion of neoantigen-specific T cells targeting medulloblastoma
Read More
2017
York Miller, M.D., Moumita Ghosh, Ph.D., & Jihye Kim, Ph.D.
Precision Chemoprevention of Lung Cancer
Read More
2017
Guido Marcucci, M.D.
Immunotherapeutic targeting of IL-1-RAP to eliminate leukemia stem cells (LSC) in Acute...
Read More
2017
Kimberly Kirkwood, M.D.
Minimally Invasive Classification of Pancreatic Cystic Neoplasms
Read More
2017
Manuel Hidalgo, Ph.D., M.D.
Autologous Dendritic Cell Vaccine for Pancreatic Cancer
Read More
2017
Alejandro Gutierrez, M.D.
JAK3 Inhibition as a Therapeutic Strategy to Reverse Chemotherapy Resistance
Read More
2017
Timothy Graubert, M.D.
ATR Inhibition as a Therapeutic Strategy for Spliceosomal-Mutant Leukemia
Read More
2017
Lucy Godley, Ph.D., M.D.
Identifying inherited variants that predispose to lymphoid malignancies
Read More
2017
Todd Fehniger, Ph.D., M.D.
Translating NK cell memory into cancer immunotherapy clinical trials
Read More
2017
Michael Engel, M.D., Ph.D.
Pre-clinical and Phase 1 clinical testing of the LSD1 inhibitor, SP-2577 in...
Read More